Spots Global Cancer Trial Database for cholangiocellular carcinoma
Every month we try and update this database with for cholangiocellular carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct | NCT01153750 | Advanced or Met... | Glivec | 18 Years - | University Hospital Dresden | |
| A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors | NCT02999672 | Bladder Cancer Pancreas Cancer Cholangiocellul... | Trastuzumab Emt... | 18 Years - | Hoffmann-La Roche | |
| Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors | NCT02156700 | Haemangioma Metastases Cholangiocellul... Hepatocellular ... Focal Nodular H... | Shear wave elas... | 18 Years - | University Hospital Dubrava | |
| Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC) | NCT01862315 | Intrahepatic Ch... Peripheral Chol... Cholangiolar Ca... Cholangiocellul... | Floxuridine (FU... dexamethasone Gemcitabine Oxaliplatin MRI Research blood ... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Cholangiocellular Carcinoma (CCC). | NCT01798147 | Intrahepatic Ch... | DEB TACE SIRT | 18 Years - | Johannes Gutenberg University Mainz | |
| Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma. | NCT01073839 | Cholangiocellul... | Cisplatin and G... | 18 Years - | University of Zurich | |
| Downsizing of Unresectable Cholangiocarcinoma by Combined Intravenous and Intra-arterial Chemotherapy | NCT01692704 | Cholangiocellul... | Selective intra... | 18 Years - | University of Zurich | |
| Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers | NCT00832637 | Hepatocellular ... Cholangiocellul... Cholangiocarcin... Bile Duct Cance... Periampullary A... Gallbladder Can... Extrahepatic Bi... | Cisplatin Erlotinib Gemcitabine | 18 Years - | New Mexico Cancer Care Alliance | |
| Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC) | NCT01862315 | Intrahepatic Ch... Peripheral Chol... Cholangiolar Ca... Cholangiocellul... | Floxuridine (FU... dexamethasone Gemcitabine Oxaliplatin MRI Research blood ... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma. | NCT01073839 | Cholangiocellul... | Cisplatin and G... | 18 Years - | University of Zurich | |
| A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors | NCT02999672 | Bladder Cancer Pancreas Cancer Cholangiocellul... | Trastuzumab Emt... | 18 Years - | Hoffmann-La Roche | |
| Downsizing of Unresectable Cholangiocarcinoma by Combined Intravenous and Intra-arterial Chemotherapy | NCT01692704 | Cholangiocellul... | Selective intra... | 18 Years - | University of Zurich | |
| Comparison of Biliary Forceps Biopsy and Brush Cytology | NCT01145248 | Cholangiocarcin... | double-balloon ... Transpapillary ... | - | University of Ulm | |
| Efficacy of Imatinib and 5-FU/Leucovorin in Patients With Advanced Carcinoma of the Gallbladder and Bile Duct | NCT01153750 | Advanced or Met... | Glivec | 18 Years - | University Hospital Dresden | |
| Downsizing of Unresectable Cholangiocarcinoma by Combined Intravenous and Intra-arterial Chemotherapy | NCT01692704 | Cholangiocellul... | Selective intra... | 18 Years - | University of Zurich | |
| A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors | NCT02999672 | Bladder Cancer Pancreas Cancer Cholangiocellul... | Trastuzumab Emt... | 18 Years - | Hoffmann-La Roche | |
| Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary Stricture | NCT01320241 | Cholangiocellul... Pancreatic Canc... Gallbladder Can... Metastatic Carc... | self-expandable... self-expandable... | 18 Years - 80 Years | Southeast University, China | |
| Adjuvant Cisplatin Plus Gemcitabine in Operable Cholangiocellular Carcinoma. | NCT01073839 | Cholangiocellul... | Cisplatin and G... | 18 Years - | University of Zurich |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
